Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Tests & Procedures
Preemptive Kidney Transplantation
How is preemptive kidney transplantation planned before dialysis, who is it suitable for, and what are its benefits and limitations? A reliable guide.
Preemptive kidney transplantation refers to kidney transplantation performed before a person starts regular dialysis. In appropriate patients, it may provide important advantages in terms of quality of life, certain clinical outcomes, and reduction of dialysis-related burdens; however, it is not automatically feasible for everyone and requires early planning. [1][2][4]
What exactly does preemptive transplantation mean?
Preemptive kidney transplantation is transplantation performed in a person whose chronic kidney disease has progressed toward kidney failure, before regular dialysis treatment begins. The central idea is to provide kidney replacement therapy directly through transplantation rather than waiting until dialysis becomes unavoidable. This approach becomes especially realistic in patients who have a suitable living donor. Undergoing transplantation without ever starting dialysis may provide advantages on multiple levels, from psychological burden to time management, but it should still be remembered that transplantation is major surgery and requires lifelong follow-up. [1][2][3]
Why is it important?
The importance of preemptive transplantation is not limited to simply bypassing dialysis. Various systematic reviews and kidney health organizations indicate that, in appropriately selected patients, there may be advantages in graft and patient outcomes, along with a reduction in dialysis-related complications and quality-of-life burden. Performing transplantation before dialysis begins may, in some patients, reduce the need for processes such as vascular access placement, adjustment to a dialysis schedule, and treatment-related daily restrictions. Even so, these advantages are not identical across all patient groups; outcomes are influenced by variables such as donor type, coexisting diseases, and transplant timing. [1][4][6]
Who may be a candidate?
Candidate evaluation begins in people with advanced chronic kidney disease who are considered medically suitable for transplantation. Estimated glomerular filtration rate, symptoms, speed of disease progression, cardiovascular status, infection risk, malignancy history, and surgical suitability are all reviewed together. Early referral is critical because transplant evaluation can take time. Particularly in patients with a potential living donor, starting the process too late may eliminate an opportunity for preemptive transplantation that could otherwise have been possible. For this reason, discussions about transplantation in progressive kidney disease should begin earlier rather than waiting until dialysis is nearly unavoidable. [1][2][5]
Why can a living donor be so decisive?
In practice, the strongest path to preemptive transplantation is often a living donor program. This is because timing can be planned more predictably, increasing the chance of scheduling surgery before dialysis becomes necessary. Preemptive transplantation is also possible while waiting for a deceased-donor organ, but waiting times and organ availability may make this more difficult. For that reason, the chances are generally better in patients who have a suitable and willing living donor. Even so, the presence of a living donor does not mean transplantation will automatically proceed. The donor’s medical suitability, ethical review, and detailed evaluation of both sides are essential. [1][2][3]
What are the advantages?
The main advantages of preemptive transplantation include reduced exposure to dialysis, less disruption of daily life, and, in some studies, improved graft or patient outcomes. There may also be benefits in terms of nutrition, reduced treatment fatigue, and overall quality of life during the pre-dialysis period. At the same time, transplantation still requires immunosuppression, carries surgical risks, and necessitates long-term follow-up. Preemptive transplantation is not the “easy option” compared with dialysis; rather, it is a transplantation strategy performed earlier in the appropriate patient. The true value of its advantages should always be judged together with the patient’s expectations and medical suitability. [1][4][6]
Why is it not suitable for every patient?
In some patients, factors such as advanced cardiovascular disease, active infection, uncontrolled malignancy, high surgical risk, or inadequate social support may limit the feasibility of preemptive transplantation. In others, the progression of kidney disease may be unpredictable, making timing more difficult. In addition, disparities in access to healthcare, early nephrology follow-up, and referral to transplant centers can create major obstacles. The literature shows that preemptive transplantation is not only a medical issue, but also an organizational and socioeconomic one. This is why the question “Why doesn’t everyone receive a transplant before dialysis?” often has a multi-layered answer. [1][3][4]
How does the evaluation process work?
The transplant process includes blood group testing, tissue compatibility assessment, infectious disease screening, cardiologic evaluation, imaging, and psychosocial review. If a living donor is involved, that person must also be evaluated independently and in detail. The patient should be counseled thoroughly about the need for immunosuppressive medications, surgical risks, and the burden of long-term follow-up. This process may feel overwhelming to some patients, but the aim is not to delay transplantation; it is to make it safe and sustainable. The success of preemptive transplantation begins long before the day of surgery, with proper preparation and timely referral. [1][2][5]
When should a transplant center be consulted?
In people with advanced chronic kidney disease, the transplant option should already be on the table when the nephrology team begins discussing kidney replacement therapies. This becomes especially important when kidney function is progressively declining, uremic symptoms are emerging, or eGFR is significantly reduced. Delaying the transplant conversation until after dialysis has started increases the risk of missing the preemptive option. For this reason, it is crucial for patients and families to receive information early, to discuss living-donor possibilities in a timely way, and not to postpone center selection. [2][5][6]
Final word: what does preemptive transplantation promise?
Preemptive kidney transplantation is a powerful strategy in the appropriate patient, but it should not be viewed as an automatic slogan of superiority. The idea of avoiding dialysis is attractive, yet transplantation has its own risks and requires lifelong monitoring. The best decision is made by considering kidney function level, coexisting diseases, donor status, and the patient’s life goals together. This content is intended for general information; the nephrology and transplant teams should determine when and under what circumstances transplantation is suitable for you. [1][4][6]
Specialist evaluation is required for personal risks, diagnostic details, and treatment selection; this content does not replace a medical examination. [1][2]
References
- 1.National Kidney Foundation — *Preemptive Transplant* — 2025 — https://www.kidney.org/kidney-topics/preemptive-transplant
- 2.NIDDK — *Prepare for Kidney Replacement Therapy* — 2025 — https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/identify-manage-patients/manage-ckd/prepare-kidney-replacement-therapy
- 3.USRDS / NIDDK — *Kidney Transplant chapter* — 2025 — https://usrds-adr.niddk.nih.gov/2025/end-stage-renal-disease/7-kidney-transplant
- 4.PubMed — *What are the benefits of preemptive versus non-preemptive kidney transplantation?* — 2023 — https://pubmed.ncbi.nlm.nih.gov/37801855/
- 5.PubMed — *Is Preemptive Kidney Transplantation Associated With Improved Outcomes?* — 2022 — https://pubmed.ncbi.nlm.nih.gov/35368639/
- 6.PubMed — *Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease* — 2023 — https://pubmed.ncbi.nlm.nih.gov/36705051/
